Literature DB >> 23955592

Differential recognition of syk-binding sites by each of the two phosphotyrosine-binding pockets of the Vav SH2 domain.

Chih-Hong Chen1, Dan Piraner, Nina M Gorenstein, Robert L Geahlen, Carol Beth Post.   

Abstract

The association of spleen tyrosine kinase (Syk), a central tyrosine kinase in B cell signaling, with Vav SH2 domain is controlled by phosphorylation of two closely spaced tyrosines in Syk linker B: Y342 and Y346. Previous studies established both singly phosphorylated and doubly phosphorylated forms play a role in signaling. The structure of the doubly phosphorylated form identified a new recognition of phosphotyrosine whereby two phosphotyrosines bind simultaneously to the Vav SH2 domain, one in the canonical pTyr pocket and one in the specificity pocket on the opposite side of the central β-sheet. It is unknown if the specificity pocket can bind phosphotyrosine independent of phosphotyrosine binding the pTyr pocket. To address this gap in knowledge, we determined the structure of the complex between Vav1 SH2 and a peptide (SykLB-YpY) modeling the singly phosphorylated-Y346 form of Syk with unphosphorylated Y342. The nuclear magnetic resonance (NMR) data conclusively establish that recognition of phosphotyrosine is swapped between the two pockets; phosphorylated pY346 binds the specificity pocket of Vav1 SH2, and unphosphorylated Y342 occupies what is normally the pTyr binding pocket. Nearly identical changes in chemical shifts occurred upon binding all three forms of singly and doubly phosphorylated peptides; however, somewhat smaller shift perturbations for SykLB-YpY from residues in regions of high internal mobility suggest that internal motions are coupled to binding affinity. The differential recognition that includes this swapped binding of phosphotyrosine to the specificity pocket of Vav SH2 increases the repertoire of possible phosphotyrosine binding by SH2 domains in regulating protein-protein interactions in cellular signaling.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  electrostatic potential surface; induced-fit binding; intermolecular nuclear Overhauser effect; internal dynamics coupled to affinity; phosphotyrosine recognition

Mesh:

Substances:

Year:  2013        PMID: 23955592      PMCID: PMC3951123          DOI: 10.1002/bip.22371

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  43 in total

1.  Vav and the B cell signalosome.

Authors:  A L DeFranco
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

2.  Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA.

Authors:  Torsten Herrmann; Peter Güntert; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

3.  The Xplor-NIH NMR molecular structure determination package.

Authors:  Charles D Schwieters; John J Kuszewski; Nico Tjandra; G Marius Clore
Journal:  J Magn Reson       Date:  2003-01       Impact factor: 2.229

Review 4.  The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.

Authors:  Bernard A Liu; Brett W Engelmann; Piers D Nash
Journal:  FEBS Lett       Date:  2012-05-05       Impact factor: 4.124

5.  Complex phosphorylation dynamics control the composition of the Syk interactome in B cells.

Authors:  Hanibal Bohnenberger; Thomas Oellerich; Michael Engelke; He-Hsuan Hsiao; Henning Urlaub; Jürgen Wienands
Journal:  Eur J Immunol       Date:  2011-05-25       Impact factor: 5.532

6.  Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.

Authors:  M Deckert; S Tartare-Deckert; C Couture; T Mustelin; A Altman
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

7.  A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.

Authors:  Peter M Hwang; Chengjun Li; Massimo Morra; Jennifer Lillywhite; D Ranjith Muhandiram; Frank Gertler; Cox Terhorst; Lewis E Kay; Tony Pawson; Julie D Forman-Kay; Shun-Cheng Li
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

8.  Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav.

Authors:  M López-Lago; H Lee; C Cruz; N Movilla; X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1.

Authors:  C K Miranti; L Leng; P Maschberger; J S Brugge; S J Shattil
Journal:  Curr Biol       Date:  1998-12-03       Impact factor: 10.834

Review 10.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21
View more
  5 in total

1.  Entropic allostery dominates the phosphorylation-dependent regulation of Syk tyrosine kinase release from immunoreceptor tyrosine-based activation motifs.

Authors:  Chao Feng; Amitava Roy; Carol Beth Post
Journal:  Protein Sci       Date:  2018-10-02       Impact factor: 6.725

2.  Distinct mechanisms of a phosphotyrosyl peptide binding to two SH2 domains.

Authors:  Xiaodong Pang; Huan-Xiang Zhou
Journal:  J Theor Comput Chem       Date:  2014-05       Impact factor: 0.939

3.  The GTPase-activating protein p120RasGAP has an evolutionarily conserved "FLVR-unique" SH2 domain.

Authors:  Rachel Jaber Chehayeb; Jessica Wang; Amy L Stiegler; Titus J Boggon
Journal:  J Biol Chem       Date:  2020-06-15       Impact factor: 5.157

4.  Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.

Authors:  Joseph A Caruso; Nicholas Carruthers; Namhee Shin; Randal Gill; Paul M Stemmer; Allen Rosenspire
Journal:  BMC Immunol       Date:  2017-07-17       Impact factor: 3.615

Review 5.  SH2 Domain Binding: Diverse FLVRs of Partnership.

Authors:  Rachel Jaber Chehayeb; Titus J Boggon
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.